The IPO is entirely an offer for sale (OFS) by promoters and existing investors who are looking to divest their stakes in the Delhi-based pharmaceutical company. The total equity shares on the block will be 40,058,844 according to the red-herring prospectus (RHP) filed by the company.
Subscribe To Our Free Newsletter |